Circulating tumor DNA in hepatocellular carcinoma: trends and challenges

被引:0
作者
Jia-Cheng Tang
Yi-Li Feng
Tao Guo
An-Yong Xie
Xiu-Jun Cai
机构
[1] Zhejiang University,Zhejiang Province Key Laboratory of Laparoscopic Technology, Sir Run Run Shaw Hospital
[2] Zhejiang University,Institute of Translational Medicine
来源
Cell & Bioscience | / 6卷
关键词
Cell free DNA; Circulating tumor DNA; Biomarker; Liquid biopsy; Hepatocellular carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
Molecular characterization of individual patients’ tumor cells is becoming increasingly important in offering effective treatment for patients in clinical practice. Recent advances in the field have indicated that circulating tumor DNA (ctDNA) has huge potential to serve as a biomarker for early detection and precision treatment as well as prognosis of hepatocellular carcinoma (HCC). As ctDNA in HCC patients harbors the molecular characteristics of HCC tumor cells, ctDNA analysis in the blood may be sufficient for convenient, non-invasive and accurate detection, providing information for HCC diagnosis, treatment and prognosis. In this review, we will summarize and discuss current trends and challenges of ctDNA application in HCC.
引用
收藏
相关论文
共 50 条
  • [21] TERT promoter mutated circulating tumor DNA as a biomarker for prognosis in hepatocellular carcinoma
    Oversoe, Stine K.
    Clement, Michelle S.
    Pedersen, Michael H.
    Weber, Britta
    Aagaard, Niels Kristian
    Villadsen, Gerda E.
    Gronbaek, Henning
    Hamilton-Dutoit, Stephen J.
    Sorensen, Boe S.
    Kelsen, Jens
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (12) : 1433 - 1440
  • [22] Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook
    Ng, Charlotte K. Y.
    Di Costanzo, Giovan Giuseppe
    Terracciano, Luigi M.
    Piscuoglio, Salvatore
    FRONTIERS IN MEDICINE, 2018, 5
  • [23] A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma
    Si-Cho Kim
    Da-Won Kim
    Eun Ju Cho
    Jin-Young Lee
    Jiwon Kim
    Chaesun Kwon
    Jeongsil Kim-Ha
    Suk Kyun Hong
    YoungRok Choi
    Nam-Joon Yi
    Kwang-Woong Lee
    Kyung-Suk Suh
    Won Kim
    Woojin Kim
    Hyunsoo Kim
    Yoon Jun Kim
    Jung-Hwan Yoon
    Su Jong Yu
    Young-Joon Kim
    Molecular Cancer, 22
  • [24] A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma
    Kim, Si-Cho
    Kim, Da-Won
    Cho, Eun Ju
    Lee, Jin-Young
    Kim, Jiwon
    Kwon, Chaesun
    Kim-Ha, Jeongsil
    Hong, Suk Kyun
    Choi, YoungRok
    Yi, Nam-Joon
    Lee, Kwang-Woong
    Suh, Kyung-Suk
    Kim, Won
    Kim, Woojin
    Kim, Hyunsoo
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Yu, Su Jong
    Kim, Young-Joon
    MOLECULAR CANCER, 2023, 22 (01)
  • [25] Circulating tumor DNA in colorectal cancer: opportunities and challenges
    Bi, Feifei
    Wang, Qiwei
    Dong, Qian
    Wang, Yuanhe
    Zhang, Liqun
    Zhang, Jingdong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (03): : 1044 - 1055
  • [26] Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma
    Nguyen, Van-Chu
    Nguyen, Trong Hieu
    Phan, Thanh Hai
    Tran, Thanh-Huong Thi
    Pham, Thu Thuy Thi
    Ho, Tan Dat
    Nguyen, Hue Hanh Thi
    Duong, Minh-Long
    Nguyen, Cao Minh
    Nguyen, Que-Tran Bui
    Bach, Hoai-Phuong Thi
    Kim, Van-Vu
    Pham, The-Anh
    Nguyen, Bao Toan
    Nguyen, Thanh Nhan Vo
    Huynh, Le Anh Khoa
    Tran, Vu Uyen
    Tran, Thuy Thi Thu
    Nguyen, Thanh Dang
    Phu, Dung Thai Bieu
    Phan, Boi Hoan Huu
    Nguyen, Quynh-Tho Thi
    Truong, Dinh-Kiet
    Do, Thanh-Thuy Thi
    Nguyen, Hoai-Nghia
    Phan, Minh-Duy
    Giang, Hoa
    Tran, Le Son
    BMC CANCER, 2023, 23 (01)
  • [27] Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma
    Van-Chu Nguyen
    Trong Hieu Nguyen
    Thanh Hai Phan
    Thanh-Huong Thi Tran
    Thu Thuy Thi Pham
    Tan Dat Ho
    Hue Hanh Thi Nguyen
    Minh-Long Duong
    Cao Minh Nguyen
    Que-Tran Bui Nguyen
    Hoai-Phuong Thi Bach
    Van-Vu Kim
    The-Anh Pham
    Bao Toan Nguyen
    Thanh Nhan Vo Nguyen
    Le Anh Khoa Huynh
    Vu Uyen Tran
    Thuy Thi Thu Tran
    Thanh Dang Nguyen
    Dung Thai Bieu Phu
    Boi Hoan Huu Phan
    Quynh-Tho Thi Nguyen
    Dinh-Kiet Truong
    Thanh-Thuy Thi Do
    Hoai-Nghia Nguyen
    Minh-Duy Phan
    Hoa Giang
    Le Son Tran
    BMC Cancer, 23
  • [28] Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma
    Li, Xuemei
    Wang, Huihui
    Li, Tao
    Wang, Lianzi
    Wu, Xian
    Liu, Jiaqing
    Xu, Yuanhong
    Wei, Wei
    CURRENT PROBLEMS IN CANCER, 2020, 44 (02)
  • [29] Prediction of the prognosis of advanced hepatocellular carcinoma by TERT promoter mutations in circulating tumor DNA
    Hirai, Mami
    Kinugasa, Hideaki
    Nouso, Kazuhiro
    Yamamoto, Shumpei
    Terasawa, Hiroyuki
    Onishi, Yuma
    Oyama, Atsushi
    Adachi, Takuya
    Wada, Nozomu
    Sakata, Masahiro
    Yasunaka, Tetsuya
    Onishi, Hideki
    Shiraha, Hidenori
    Takaki, Akinobu
    Okada, Hiroyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (04) : 1118 - 1125
  • [30] Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
    Li, Lingyu
    Sun, Yingli
    MEDCOMM, 2024, 5 (11):